Chris Shibutani's Stock Ratings

Goldman Sachs Analyst

Chris Shibutani is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025

Overall Average Return

0.85%

Smart Score

54.4%

Overall Average Return Percentile

40th

Number of Ratings

114
Buy NowGet Alert
03/14/2025MCRBBuy Now
Seres Therapeutics
$0.77-2.58%
Chris Shibutani54%
$1 → $0.75MaintainsSellGet Alert
02/14/2025ALKSBuy Now
Alkermes
$34.56-7.41%
Chris Shibutani54%
$30 → $32MaintainsBuyGet Alert
12/20/2024PCVXBuy Now
Vaxcyte
$74.4781.28%
Chris Shibutani54%
→ $135Initiates → BuyGet Alert
11/08/2024BNTXBuy Now
BioNTech
$98.9738.42%
Chris Shibutani54%
$90 → $137UpgradeNeutral → BuyGet Alert
11/07/2024SNDXBuy Now
Syndax Pharmaceuticals
$12.75158.82%
Chris Shibutani54%
$30 → $33MaintainsBuyGet Alert
11/01/2024UTHRBuy Now
United Therapeutics
$310.88-2.86%
Chris Shibutani54%
$243 → $302MaintainsNeutralGet Alert
10/25/2024ALKSBuy Now
Alkermes
$34.56-13.19%
Chris Shibutani54%
$32 → $30MaintainsBuyGet Alert
10/25/2024ERASBuy Now
Erasca
$1.46139.73%
Chris Shibutani54%
$3 → $3.5MaintainsBuyGet Alert
08/14/2024ERASBuy Now
Erasca
$1.46105.48%
Chris Shibutani54%
$4 → $3MaintainsBuyGet Alert
08/14/2024RPRXBuy Now
Royalty Pharma
$33.2353.45%
Chris Shibutani54%
$50 → $51MaintainsBuyGet Alert
07/19/2024JNJBuy Now
Johnson & Johnson
$162.41-4.56%
Chris Shibutani54%
$160 → $155MaintainsNeutralGet Alert
07/12/2024AMLXBuy Now
Amylyx Pharma
$3.649.89%
Chris Shibutani54%
$3 → $4MaintainsNeutralGet Alert
05/28/2024ERASBuy Now
Erasca
$1.46173.97%
Chris Shibutani54%
$7 → $4MaintainsBuyGet Alert
05/13/2024RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
$9 → $8MaintainsNeutralGet Alert
05/06/2024OGNBuy Now
Organon
$15.6327.96%
Chris Shibutani54%
$18 → $20MaintainsNeutralGet Alert
05/03/2024UTHRBuy Now
United Therapeutics
$310.88-22.8%
Chris Shibutani54%
$218 → $240MaintainsNeutralGet Alert
05/03/2024OGNBuy Now
Organon
$15.6327.96%
Chris Shibutani54%
$18 → $20MaintainsNeutralGet Alert
04/11/2024LLYBuy Now
Eli Lilly and Co
$831.24-13.02%
Chris Shibutani54%
$650 → $723MaintainsNeutralGet Alert
04/02/2024ERASBuy Now
Erasca
$1.46379.45%
Chris Shibutani54%
$6 → $7MaintainsBuyGet Alert
03/11/2024AMLXBuy Now
Amylyx Pharma
$3.649.89%
Chris Shibutani54%
$40 → $4DowngradeBuy → NeutralGet Alert
03/01/2024SDGRBuy Now
Schrodinger
$22.8014.04%
Chris Shibutani54%
$29 → $26MaintainsNeutralGet Alert
03/01/2024RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
$8 → $9MaintainsNeutralGet Alert
02/28/2024BNTXBuy Now
BioNTech
$98.971.04%
Chris Shibutani54%
$113 → $100MaintainsNeutralGet Alert
02/20/2024RPRXBuy Now
Royalty Pharma
$33.2350.44%
Chris Shibutani54%
$56 → $50MaintainsBuyGet Alert
02/20/2024OGNBuy Now
Organon
$15.6315.16%
Chris Shibutani54%
$16 → $18MaintainsNeutralGet Alert
02/12/2024UTHRBuy Now
United Therapeutics
$310.88-30.84%
Chris Shibutani54%
$213 → $215UpgradeSell → NeutralGet Alert
01/25/2024NBIXBuy Now
Neurocrine Biosciences
$110.0838.98%
Chris Shibutani54%
$134 → $153MaintainsBuyGet Alert
01/09/2024RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
$30 → $8DowngradeBuy → NeutralGet Alert
12/11/2023ABBVBuy Now
AbbVie
$211.28-18.12%
Chris Shibutani54%
→ $173UpgradeNeutral → BuyGet Alert
11/10/2023AMLXBuy Now
Amylyx Pharma
$3.64998.9%
Chris Shibutani54%
$46 → $40MaintainsBuyGet Alert
11/09/2023NKTRBuy Now
Nektar Therapeutics
$0.86
Chris Shibutani54%
UpgradeMarket Perform → OutperformGet Alert
11/03/2023MCRBBuy Now
Seres Therapeutics
$0.7762.36%
Chris Shibutani54%
$4 → $1.25MaintainsSellGet Alert
11/03/2023OGNBuy Now
Organon
$15.632.37%
Chris Shibutani54%
$33 → $16DowngradeBuy → NeutralGet Alert
10/30/2023BMYBuy Now
Bristol-Myers Squibb
$59.4816%
Chris Shibutani54%
$81 → $69MaintainsBuyGet Alert
10/11/2023SNDXBuy Now
Syndax Pharmaceuticals
$12.75135.29%
Chris Shibutani54%
→ $30Initiates → BuyGet Alert
09/21/2023RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
$38 → $33MaintainsBuyGet Alert
08/10/2023LLYBuy Now
Eli Lilly
$831.24-43.46%
Chris Shibutani54%
$385 → $470MaintainsNeutralGet Alert
08/09/2023LLYBuy Now
Eli Lilly
$831.24-43.46%
Chris Shibutani54%
$385 → $470MaintainsNeutralGet Alert
07/24/2023AMLXBuy Now
Amylyx Pharma
$3.641246.15%
Chris Shibutani54%
$45 → $49UpgradeNeutral → BuyGet Alert
05/16/2023ERASBuy Now
Erasca
$1.46516.44%
Chris Shibutani54%
$10 → $9MaintainsBuyGet Alert
05/10/2023EQRXBuy Now
EQRx
Chris Shibutani54%
$5 → $3MaintainsNeutralGet Alert
03/28/2023BNTXBuy Now
BioNTech
$98.9741.45%
Chris Shibutani54%
$156 → $140MaintainsNeutralGet Alert
03/14/2023AMLXBuy Now
Amylyx Pharma
$3.641191.21%
Chris Shibutani54%
$41 → $47MaintainsNeutralGet Alert
03/03/2023INVABuy Now
Innoviva
$17.20-24.44%
Chris Shibutani54%
$15 → $13MaintainsNeutralGet Alert
03/01/2023RVMDBuy Now
Revolution Medicines
$38.30-39.95%
Chris Shibutani54%
$20 → $23MaintainsNeutralGet Alert
02/27/2023NKTRBuy Now
Nektar Therapeutics
$0.86132.48%
Chris Shibutani54%
$3 → $2MaintainsSellGet Alert
02/24/2023ERASBuy Now
Erasca
$1.46584.93%
Chris Shibutani54%
→ $10Initiates → BuyGet Alert
01/31/2023RXDXBuy Now
Prometheus Biosciences
Chris Shibutani54%
$117 → $144MaintainsBuyGet Alert
01/31/2023BNTXBuy Now
BioNTech
$98.9757.62%
Chris Shibutani54%
$177 → $156MaintainsNeutralGet Alert
12/19/2022VTYXBuy Now
Ventyx Biosciences
$1.373549.9%
Chris Shibutani54%
→ $50Initiates → BuyGet Alert
12/16/2022KYMRBuy Now
Kymera Therapeutics
$33.2056.63%
Chris Shibutani54%
$40 → $52MaintainsBuyGet Alert
12/13/2022PFEBuy Now
Pfizer
$26.15129.45%
Chris Shibutani54%
$47 → $60UpgradeNeutral → BuyGet Alert
12/05/2022UTHRBuy Now
United Therapeutics
$310.88-26.02%
Chris Shibutani54%
→ $230Initiates → SellGet Alert
11/11/2022EQRXBuy Now
EQRx
Chris Shibutani54%
$8 → $5DowngradeBuy → NeutralGet Alert
11/08/2022TRDABuy Now
Entrada Therapeutics
$10.4771.92%
Chris Shibutani54%
$13 → $18MaintainsNeutralGet Alert
11/08/2022LLYBuy Now
Eli Lilly
$831.24-62.35%
Chris Shibutani54%
$281 → $313MaintainsNeutralGet Alert
11/08/2022BNTXBuy Now
BioNTech
$98.9778.83%
Chris Shibutani54%
$200 → $177MaintainsNeutralGet Alert
09/22/2022RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
→ $33Initiates → BuyGet Alert
09/09/2022AMLXBuy Now
Amylyx Pharma
$3.64998.9%
Chris Shibutani54%
$22 → $40MaintainsNeutralGet Alert
08/16/2022TRDABuy Now
Entrada Therapeutics
$10.4724.16%
Chris Shibutani54%
$10 → $13MaintainsNeutralGet Alert
08/03/2022KYMRBuy Now
Kymera Therapeutics
$33.2020.48%
Chris Shibutani54%
→ $40Initiates → BuyGet Alert
07/20/2022INVABuy Now
Innoviva
$17.20-7%
Chris Shibutani54%
→ $16Initiates → NeutralGet Alert
07/20/2022RXDXBuy Now
Prometheus Biosciences
Chris Shibutani54%
→ $51Initiates → BuyGet Alert
06/13/2022EQRXBuy Now
EQRx
Chris Shibutani54%
→ $8Initiates → BuyGet Alert
05/24/2022EXAIBuy Now
Exscientia
Chris Shibutani54%
$23 → $20MaintainsBuyGet Alert
05/24/2022TRDABuy Now
Entrada Therapeutics
$10.47-4.49%
Chris Shibutani54%
$22 → $10MaintainsNeutralGet Alert
05/24/2022BNTXBuy Now
BioNTech
$98.97108.13%
Chris Shibutani54%
$255 → $206MaintainsNeutralGet Alert
04/27/2022OGNBuy Now
Organon
$15.63155.92%
Chris Shibutani54%
→ $40Initiates → BuyGet Alert
04/27/2022RPRXBuy Now
Royalty Pharma
$33.2368.5%
Chris Shibutani54%
→ $56Initiates → BuyGet Alert
04/20/2022ALKSBuy Now
Alkermes
$34.561.27%
Chris Shibutani54%
→ $35Initiates → BuyGet Alert
04/18/2022NKTRBuy Now
Nektar Therapeutics
$0.86248.72%
Chris Shibutani54%
→ $3DowngradeNeutral → SellGet Alert
04/12/2022JNJBuy Now
Johnson & Johnson
$162.4111.45%
Chris Shibutani54%
$163 → $181MaintainsNeutralGet Alert
04/12/2022LLYBuy Now
Eli Lilly
$831.24-68.24%
Chris Shibutani54%
$234 → $264MaintainsNeutralGet Alert
04/12/2022ABBVBuy Now
AbbVie
$211.28-33.74%
Chris Shibutani54%
$122 → $140MaintainsNeutralGet Alert
04/01/2022AMLXBuy Now
Amylyx Pharma
$3.64174.73%
Chris Shibutani54%
$36 → $10DowngradeBuy → NeutralGet Alert
02/25/2022NBIXBuy Now
Neurocrine Biosciences
$110.084.46%
Chris Shibutani54%
→ $115UpgradeNeutral → BuyGet Alert
02/03/2022ABBVBuy Now
AbbVie
$211.28-42.26%
Chris Shibutani54%
$117 → $122MaintainsNeutralGet Alert
02/01/2022AMLXBuy Now
Amylyx Pharma
$3.64889.01%
Chris Shibutani54%
→ $36Initiates → BuyGet Alert
12/17/2021ABBVBuy Now
AbbVie
$211.28-46.52%
Chris Shibutani54%
→ $113Initiates → NeutralGet Alert
12/17/2021PFEBuy Now
Pfizer
$26.1595.03%
Chris Shibutani54%
→ $51Initiates → NeutralGet Alert
12/17/2021JNJBuy Now
Johnson & Johnson
$162.41-0.87%
Chris Shibutani54%
→ $161Initiates → NeutralGet Alert
12/17/2021LLYBuy Now
Eli Lilly
$831.24-71.61%
Chris Shibutani54%
→ $236Initiates → NeutralGet Alert
12/17/2021BMYBuy Now
Bristol-Myers Squibb
$59.4821.04%
Chris Shibutani54%
→ $72Initiates → BuyGet Alert
11/23/2021TRDABuy Now
Entrada Therapeutics
$10.47176.98%
Chris Shibutani54%
→ $29Initiates → NeutralGet Alert
10/26/2021EXAIBuy Now
Exscientia
Chris Shibutani54%
→ $30Initiates → BuyGet Alert
09/07/2021TNGXBuy Now
Tango Therapeutics
$1.75871.43%
Chris Shibutani54%
→ $17Initiates → BuyGet Alert
08/12/2021RVMDBuy Now
Revolution Medicines
$38.30-29.5%
Chris Shibutani54%
$49 → $27DowngradeBuy → NeutralGet Alert
07/23/2021MCRBBuy Now
Seres Therapeutics
$0.77809.21%
Chris Shibutani54%
$24 → $7DowngradeNeutral → SellGet Alert
05/18/2021ARNABuy Now
Arena Pharmaceuticals
Chris Shibutani54%
→ $90Initiates → BuyGet Alert
05/18/2021BNTXBuy Now
BioNTech
$98.9774.79%
Chris Shibutani54%
→ $173Initiates → NeutralGet Alert
05/18/2021RVMDBuy Now
Revolution Medicines
$38.3027.94%
Chris Shibutani54%
→ $49Initiates → BuyGet Alert
07/14/2020RPTXBuy Now
Repare Therapeutics
$1.13
Chris Shibutani54%
Initiates → OutperformGet Alert
02/10/2020ARDXBuy Now
Ardelyx
$5.21
Chris Shibutani54%
Initiates → OutperformGet Alert
01/10/2020ADROBuy Now
Aduro Biotech
Chris Shibutani54%
DowngradeOutperform → Market PerformGet Alert
07/15/2019ALKSBuy Now
Alkermes
$34.56-21.88%
Chris Shibutani54%
→ $27UpgradeSell → NeutralGet Alert
05/28/2019BMYBuy Now
Bristol-Myers Squibb
$59.48-9.22%
Chris Shibutani54%
→ $54Initiates → BuyGet Alert
12/19/2018ALKSBuy Now
Alkermes
$34.56-24.77%
Chris Shibutani54%
$49 → $26DowngradeNeutral → SellGet Alert
01/24/2018PBYIBuy Now
Puma Biotechnology
$3.42
Chris Shibutani54%
DowngradeOutperform → Market PerformGet Alert
12/21/2017MRTXBuy Now
Mirati Therapeutics
Chris Shibutani54%
Initiates → OutperformGet Alert
11/07/2017NKTRBuy Now
Nektar Therapeutics
$0.86
Chris Shibutani54%
Initiates → OutperformGet Alert
07/18/2017ADROBuy Now
Aduro Biotech
Chris Shibutani54%
Initiates → OutperformGet Alert
05/25/2017PBYIBuy Now
Puma Biotechnology
$3.42
Chris Shibutani54%
UpgradeMarket Perform → OutperformGet Alert
05/02/2017RDUSBuy Now
Radius Health
$29.05
Chris Shibutani54%
DowngradeOutperform → Market PerformGet Alert
03/24/2017FPRXBuy Now
Five Prime Therapeutics
Chris Shibutani54%
Initiates → OutperformGet Alert
03/24/2017SNDXBuy Now
Syndax Pharmaceuticals
$12.75
Chris Shibutani54%
Initiates → OutperformGet Alert
05/06/2016RDUSBuy Now
Radius Health
$29.05
Chris Shibutani54%
Assumes → OutperformGet Alert
07/21/2015MCRBBuy Now
Seres Therapeutics
$0.774575.93%
Chris Shibutani54%
→ $36Initiates → NeutralGet Alert
05/05/2015PBYIBuy Now
Puma Biotechnology
$3.42
Chris Shibutani54%
DowngradeOutperform → Market PerformGet Alert
07/16/2014RDUSBuy Now
Radius Health
$29.05
Chris Shibutani54%
Initiates → OutperformGet Alert
01/05/2014ALKSBuy Now
Alkermes
$34.567.06%
Chris Shibutani54%
$25 → $37MaintainsNeutralGet Alert
12/19/2012BMYBuy Now
Bristol-Myers Squibb
$59.48-34.44%
Chris Shibutani54%
$40 → $39MaintainsBuyGet Alert
11/13/2012PBYIBuy Now
Puma Biotech
$3.42
Chris Shibutani54%
Initiates → OutperformGet Alert
09/11/2012BMYBuy Now
Bristol-Myers Squibb
$59.48-32.76%
Chris Shibutani54%
$38 → $40UpgradeBuy → BuyGet Alert
05/18/2012ALKSBuy Now
Alkermes
$34.56-50.81%
Chris Shibutani54%
$18 → $17MaintainsNeutralGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free